Table 1.
eMS | BMI-methylation |
BMI-gene expression |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Indirect |
Direct |
|||||||||
CpG ID | CpG location | β | SE | P value | FDR | Gene | β | P value | β | P value |
cg06500161 | Body (ABCG1) | 0.005 | 0.001 | 2.8E-07 | 5.4E-04 | ABCG1 | −0.005 | 2.6E-06 | −0.025 | 3.7E-12 |
cg05323251 | Body (ICAM3) | 0.003 | 0.001 | 3.0E-06 | 2.9E-03 | LDLR | 0.001 | 2.4E-03 | 0.012 | 1.5E-07 |
cg10192877 | Body (ABCG1) | 0.004 | 0.001 | 5.3E-05 | 0.02 | ABCG1 | −0.002 | 1.1E-03 | −0.025 | 3.6E-14 |
cg05119988 | 5′UTR (SC4MOL) | −0.006 | 0.001 | 1.0E-04 | 0.03 | SC4MOL | 0.001 | 1.2E-03 | 0.009 | 1.2E-06 |
Effects of BMI on methylation of cyan module gene eMS (β, SE, P value, and genome-wide FDR) and the indirect (mediated) and direct effects (β, P value) of BMI on gene expression. Indirect effects were estimated using SEM for methylation mediating the effect of BMI on gene expression (log2 fold change of expression per 1-unit increase in BMI [kg/m2]). Some eMS were located within gene bodies (gene containing CpG in parentheses) or in the 5′ untranslated regions (UTR) of genes. Analyses included 1,264 CD14+ monocyte samples and were adjusted for age, sex, race, study site, and residual sample contamination with nonmonocytes.